These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
389 related articles for article (PubMed ID: 8556268)
21. Effect of GK-128 [2-[(2-methylimidazol-1-yl)methyl]-benzo[f]thiochromen-1-one monohydrochloride hemihydrate], a selective 5-hydroxytryptamine3 receptor antagonist, on colonic function in rats. Ito C; Isobe Y; Kawamura R; Kiuchi Y; Tsuchida K; Higuchi S J Pharmacol Exp Ther; 1997 Jan; 280(1):67-72. PubMed ID: 8996183 [TBL] [Abstract][Full Text] [Related]
22. 5-Methoxytryptamine and 2-methyl-5-hydroxytryptamine-induced desensitization as a discriminative tool for the 5-HT3 and putative 5-HT4 receptors in guinea pig ileum. Craig DA; Eglen RM; Walsh LK; Perkins LA; Whiting RL; Clarke DE Naunyn Schmiedebergs Arch Pharmacol; 1990 Jul; 342(1):9-16. PubMed ID: 2402303 [TBL] [Abstract][Full Text] [Related]
23. Several receptor subtypes contribute to 5-hydroxytryptamine-induced secretion by rat ileum in-vitro. Hardcastle J; Hardcastle PT J Pharm Pharmacol; 1997 Nov; 49(11):1114-20. PubMed ID: 9401948 [TBL] [Abstract][Full Text] [Related]
24. Evidence that the secretory response of rat intestine to 5-hydroxytryptamine in-vivo involves more than one 5-hydroxytryptamine-receptor subtype. Hardcastle J; Hardcastle PT J Pharm Pharmacol; 1995 Sep; 47(9):744-9. PubMed ID: 8583387 [TBL] [Abstract][Full Text] [Related]
25. Modulation of norepinephrine release by serotonergic receptors in the rat hippocampus as measured by in vivo microdialysis. Matsumoto M; Yoshioka M; Togashi H; Tochihara M; Ikeda T; Saito H J Pharmacol Exp Ther; 1995 Mar; 272(3):1044-51. PubMed ID: 7891314 [TBL] [Abstract][Full Text] [Related]
27. Pharmacological properties of quinoxaline derivatives as a new class of 5-HT3 receptor antagonists. Lasheras B; Berjón A; Montañés R; Roca J; Romero G; Ramírez MJ; Del Río J Arzneimittelforschung; 1996 Apr; 46(4):401-6. PubMed ID: 8740088 [TBL] [Abstract][Full Text] [Related]
28. Effect of FK1052, a potent 5-hydroxytryptamine3 and 5-hydroxytryptamine4 receptor dual antagonist, on colonic function in vivo. Kadowaki M; Nagakura Y; Tomoi M; Mori J; Kohsaka M J Pharmacol Exp Ther; 1993 Jul; 266(1):74-80. PubMed ID: 8331576 [TBL] [Abstract][Full Text] [Related]
29. Characterization of the receptors involved in the 5-HT-induced excitation of canine antral longitudinal muscle. Prins NH; Akkermans LM; Lefebvre RA; Schuurkes JA Br J Pharmacol; 2001 Nov; 134(6):1351-9. PubMed ID: 11704657 [TBL] [Abstract][Full Text] [Related]
30. The involvement of the serotonergic transmission system in neonatal and adult rat ileum contractility varies with age. Lobo SB; Denyer M; Britland S; Javid FA Pharmacology; 2011; 88(3-4):225-32. PubMed ID: 21997518 [TBL] [Abstract][Full Text] [Related]
31. Review article: serotonin receptors and transporters -- roles in normal and abnormal gastrointestinal motility. Gershon MD Aliment Pharmacol Ther; 2004 Nov; 20 Suppl 7():3-14. PubMed ID: 15521849 [TBL] [Abstract][Full Text] [Related]
33. Expression of 5-HT3 receptors by extrinsic duodenal afferents contribute to intestinal inhibition of gastric emptying. Raybould HE; Glatzle J; Robin C; Meyer JH; Phan T; Wong H; Sternini C Am J Physiol Gastrointest Liver Physiol; 2003 Mar; 284(3):G367-72. PubMed ID: 12409280 [TBL] [Abstract][Full Text] [Related]
34. Pinacidil suppression on 5-HT3 receptor-mediated contraction of guinea pig ileum in vitro. Yuan YM; Xu DY; Hu GY Zhongguo Yao Li Xue Bao; 1998 Jan; 19(1):31-5. PubMed ID: 10375754 [TBL] [Abstract][Full Text] [Related]
35. 5-HT induces cAMP production in crypt colonocytes at a 5-HT4 receptor. Albuquerque FC; Smith EH; Kellum JM J Surg Res; 1998 Jul; 77(2):137-40. PubMed ID: 9733600 [TBL] [Abstract][Full Text] [Related]
36. Serotonergic modulation of the release of endogenous norepinephrine from rat hypothalamic slices. Blandina P; Goldfarb J; Walcott J; Green JP J Pharmacol Exp Ther; 1991 Jan; 256(1):341-7. PubMed ID: 1988665 [TBL] [Abstract][Full Text] [Related]
37. Roles of serotonin receptor subtypes for the antinociception of 5-HT in the spinal cord of rats. Jeong CY; Choi JI; Yoon MH Eur J Pharmacol; 2004 Oct; 502(3):205-11. PubMed ID: 15476746 [TBL] [Abstract][Full Text] [Related]
38. Use of intravenous microdialysis to monitor changes in serotonin release and metabolism induced by cisplatin in cancer patients: comparative effects of granisetron and ondansetron. Castejon AM; Paez X; Hernandez L; Cubeddu LX J Pharmacol Exp Ther; 1999 Dec; 291(3):960-6. PubMed ID: 10565811 [TBL] [Abstract][Full Text] [Related]
39. Pharmacological characterization of the 5-hydroxytryptamine receptor mediating relaxation in the rat isolated ileum. Tuladhar BR; Costall B; Naylor RJ Br J Pharmacol; 1996 Sep; 119(2):303-10. PubMed ID: 8886413 [TBL] [Abstract][Full Text] [Related]
40. Anxiolytic-like effect of a serotonergic ligand with high affinity for 5-HT1A, 5-HT2A and 5-HT3 receptors. Delgado M; Caicoya AG; Greciano V; Benhamú B; López-Rodríguez ML; Fernández-Alfonso MS; Pozo MA; Manzanares J; Fuentes JA Eur J Pharmacol; 2005 Mar; 511(1):9-19. PubMed ID: 15777774 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]